# Outpace Bio, Inc. — Form D

Outpace Bio, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-01. The offering totals $144.2M, of which $56.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-01
- Form: D
- Accession: 0002031531-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $144.2M
- Amount sold: $56.0M
- Remaining: $88.2M
- Investors: 25
- Date of first sale: 2024-07-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520350

## Issuer

- Name: Outpace Bio, Inc.
- CIK: 0002031531
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 700 Dexter Ave N, Suite 300, SEATTLE, WA, 98109
- Phone: 206-422-1367

## Officers, directors & promoters (12)

| Name | Role | Location |
| --- | --- | --- |
| Vasudev Bailey | Director | New Yoprk City, NY |
| Scott Boyken | Director | Seattle, WA |
| Bahija Jallal | Director | Seattle, WA |
| Marc Lajoie | Director | Seattle, WA |
| Jake Simson | Director | San Mateo, CA |
| Scott Boyken | Executive Officer | Seattle, WA |
| Aaron Foster | Executive Officer | Seattle, WA |
| Marc Lajoie | Executive Officer | Seattle, WA |
| Charity Scripture | Executive Officer | Seattle, WA |
| Eric Soller | Executive Officer | Seattle, WA |
| Scott Boyken | Promoter | Seattle, WA |
| Marc Lajoie | Promoter | Seattle, WA |

## More

- [CIK 2031531 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2031531&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002031531-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.